Location History:
- Kanagawa, JP (2014 - 2020)
- Fujisawa Kanagawa, JP (2021 - 2023)
Company Filing History:
Years Active: 2014-2024
Title: Yusuke Tominari: Innovator in Cyclic Dinucleotide Research
Introduction
Yusuke Tominari is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compounds with STING agonistic activity. With a total of 10 patents to his name, Tominari's work is paving the way for advancements in the treatment of STING-related diseases.
Latest Patents
Tominari's latest patents include innovative methods for making cyclic dinucleotides. One of his notable disclosures provides a compound that exhibits STING agonistic activity, which may be beneficial for the prophylaxis or treatment of STING-related diseases. This patent outlines a compound represented by a specific formula, where each symbol is defined in the detailed description. Another significant patent focuses on antibody-drug conjugates that also incorporate cyclic dinucleotides, further emphasizing the potential therapeutic applications of his research.
Career Highlights
Yusuke Tominari is currently associated with Takeda Pharmaceutical Company Limited, where he continues to explore and develop groundbreaking biopharmaceuticals. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges through scientific research.
Collaborations
Tominari collaborates with esteemed colleagues, including Yusuke Sasaki and Shinichi Imamura. These partnerships enhance the research environment and contribute to the successful development of new therapeutic strategies.
Conclusion
Yusuke Tominari's contributions to the field of cyclic dinucleotide research are noteworthy and impactful. His innovative patents and collaborations position him as a key figure in the advancement of treatments for STING-related diseases.